Neil Martin

Featured in: Favicon

tandfonline.com Favicon

europeanurology.com Favicon

callcentrehelper.com Favicon

ajet.org.au Favicon

academic.oup.com

Articles

Reply to: Response and remission in asthma with tezepelumab: overlapping concepts informing on type-2 inflammatory-dependent treatment effects

2 months ago | publications.ersnet.org | Neil Martin |Michael E. Wechsler |Christopher E. Brightling

Reply to S. Mailhot-Larouche and co-workers:We thank S. Mailhot-Larouche and co-workers for their interest in our recent publication on clinical response and clinical remission with tezepelumab treatment, reporting results over 2 years from patients with severe, uncontrolled asthma enrolled in the NAVIGATOR and DESTINATION clinical trials [1].

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →